Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Pharmaceuticals ETF (XPH)

45.74
Delayed Data
As of Jan 12
 +0.32 / +0.70%
Today’s Change
37.16
Today|||52-Week Range
45.94
+5.15%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.

Performance

1 month+4.96% 3 years-3.60%
3 months+6.19% 5 years+12.61%
1 year+16.40% Since inception+12.03%
Data through 01/13/2018

Quote Details

Previous close$45.42
Open day’s range45.51 – 45.94
Net asset value (NAV)45.75 (01/12/2018)
Daily volume37,504
Average volume (3 months)110,416
Data as of 3:59pm ET, 01/12/2018

Peer Comparisonvs. Health ETFs

 XPHCategory
Performance 5-yr return+12.61%+17.28%
Expense Gross exp ratio0.35%1.32%
Risk 5 year sharpe ratio0.671.11
Net assets$378.4M$3.0B
Average market cap$8.8B$9.3B
Average P/E27.321.7
Dividend / Share--0.33%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MYL Mylan NV4.75%
PRGO Perrigo Company PLC4.42%
PFE Pfizer4.40%
MRK Merck4.39%
MNK Mallinckrodt Plc4.39%
ZTS Zoetis Inc4.35%
ENDP Endo International PLC4.33%
JNJ Johnson & Johnson4.31%
BMY Bristol-Myers Squibb4.26%
AKRX Akorn Inc4.25%